Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Idiopathic Inflammatory Myopathy”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Looking for participantsNCT05895786
What this trial is testing

Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

Who this might be right for
Myositis
Pfizer 318
Not applicableStudy completedNCT03092167
What this trial is testing

Physical Training in Patients With Idiopathic Inflammatory Myopathies

Who this might be right for
Idiopathic Inflammatory MyopathiesPhysical Activity
University of Sao Paulo 12
Not applicableNot Yet RecruitingNCT06460766
What this trial is testing

Validity and Reliability of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity Questionnaire

Who this might be right for
Rheumatic DiseasesPediatric ALLChildren, Only
Istanbul University - Cerrahpasa 70
Early research (Phase 1)Ended earlyNCT06524687
What this trial is testing

Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies

Who this might be right for
Idiopathic Inflammatory MyopathiesInflammatory Myopathies
IGM Biosciences, Inc. 2
Post-approval studies (Phase 4)Active Not RecruitingNCT05879419
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondylitis, AnkylosingSpondyloarthritis+8 more
University of Sao Paulo General Hospital 2,005
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07103746
What this trial is testing

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Who this might be right for
Autoimmune Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05379634
What this trial is testing

Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

Who this might be right for
Myositis
Janssen Research & Development, LLC 36
Not applicableUnknownNCT05027152
What this trial is testing

Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisPolymyositis
Federal University of Espirito Santo 30
Testing effectiveness (Phase 2)Study completedNCT04628936
What this trial is testing

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Large-scale testing (Phase 3)Study completedNCT02971683
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
PolymyositisDermatomyositisAutoimmune Necrotizing Myopathy+2 more
Bristol-Myers Squibb 149
Very early researchEnded earlyNCT06462144
What this trial is testing

IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy

Who this might be right for
Systemic Lupus Erythematosus (SLE)ANCA Associated Vasculitis (AAV)Idiopathic Inflammatory Myopathy (IIM)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 3
Testing effectiveness (Phase 2)UnknownNCT04237987
What this trial is testing

Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy

Who this might be right for
Inflammatory Myopathy
Peking University People's Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06154252
What this trial is testing

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Who this might be right for
Idiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase Syndrome+5 more
Cabaletta Bio 24
Very early researchTemporarily pausedNCT06549296
What this trial is testing

Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisANCA Associated Vasculitis+3 more
Nanjing Bioheng Biotech Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT04033926
What this trial is testing

KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Kezar Life Sciences, Inc. 25
Early research (Phase 1)Not Yet RecruitingNCT07229144
What this trial is testing

OM336 in Seropositive Autoimmune Diseases

Who this might be right for
Sjogrens DiseaseIdiopathic Inflammatory Myopathy (IIM)
Ouro Medicines 39
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Large-scale testing (Phase 3)Enrolling By InvitationNCT05979441
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Who this might be right for
MyositisActive Idiopathic Inflammatory MyopathyDermatomyositis+3 more
argenx 240